Bradway Robert A, of Amgen Inc. (NASDAQ:AMGN), sold 492,643 shares of company stock on March 04, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The shares were sold at an average price of $379.27 per share, for a total transaction value of $32.0M. Following this transaction, Bradway Robert A still owns 492,643 shares of Amgen Inc. stock.
Amgen Inc.'s stock currently trades at $369.53, giving the company a market capitalization of $209.2B.
Insider sales are common and don't necessarily indicate a bearish outlook. Executives regularly sell shares for tax planning, diversification, or personal liquidity. The key factors to watch are the size of the sale relative to the insider's total holdings, whether multiple insiders are selling simultaneously, and whether the trades occur near earnings announcements or other catalysts.
At $32.0 million, this transaction stands out as a significant commitment. Trades of this size from corporate insiders typically attract attention from institutional investors and analysts who track Form 4 filings for early signals about company direction.
Insider transaction data is reported to the SEC via Form 4 filings, typically within two business days of the trade. Investors can track insider activity alongside other metrics — such as institutional flows, short interest, and technical indicators — to build a more complete picture of market sentiment around Amgen Inc..